Both in Pharmaceuticals
Rein Therapeutics vs Xilio Therapeutics
Over the past year RNTX returned −61.9% and XLO returned −27.1%; their daily moves had a correlation of 0.01.
RNTX −61.9% XLO −27.1%Growth of $1, one year, split-adjusted
| Metric | RNTX | XLO |
|---|---|---|
| Price | $0.6675 | $8.68 |
| Market cap | $57.6M | $57.1M |
| Today | +5.05% | +8.64% |
| 1 month | −19.1% | −4.7% |
| 6 months | −34.6% | +12.6% |
| Year to date | −42.5% | −3.2% |
| 1 year | −57.3% | −22.2% |
| Revenue growth (YoY) | — | +131.2% |
| Gross margin | — | 100.0% |
| Net margin | — | −34.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.9× |
| Net cash | $40.6M | $136.0M |
| Dividend yield | — | — |
| Volatility (60d) | 96.0% | 38.3% |
| Short % of float | 2.6% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).